Survival in primary lung cancer potentially cured by operation:: Influence of tumor stage and clinical characteristics

被引:22
作者
Myrdal, G [1 ]
Lambe, M
Gustafsson, G
Nilsson, K
Ståhle, E
机构
[1] Univ Uppsala Hosp, Dept Thorac & Cardiovasc Surg, SE-75185 Uppsala, Sweden
[2] Univ Uppsala Hosp, Dept Oncol, SE-75185 Uppsala, Sweden
[3] Karolinska Inst, Dept Med Epidemiol, Stockholm, Sweden
关键词
D O I
10.1016/S0003-4975(02)04321-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Surgical resection is currently standard treatment in early stage lung cancer. The aim of the present study was to identify stage-related factors and patient characteristics influencing survival after complete resection. Methods. We identified 395 patients with non-small cell lung cancer who had undergone potentially radical operation during 1987 to 1999 at one thoracic surgery institution in central Sweden. Factors independently related to survival were identified in a multivariate analysis. Survival was analyzed in low-, medium-, and high-risk groups based on a risk score calculated from relative hazards for identified risk factors. Results. Overall 5-year survival among the 395 patients was 51%. The strongest factor predicting prognosis was positive lymph nodes at operation. Higher age, earlier period for operation, impaired lung function, current smoking, and major operative complication were all related to poorer prognosis. Patients with tumor stage Ia had a 5-year survival of 69%, compared to 73% in patients in the low-risk group. Conclusions. Tumor stage is the best prognostic indicator after radical operation. Inclusion of other tumor and patient-related variables did not add prognostic information of clinical relevance beyond that provided by tumor stage alone. (C) 2003 by The Society of Thoracic Surgeons.
引用
收藏
页码:356 / 363
页数:8
相关论文
共 20 条
[1]  
COX DR, 1972, J R STAT SOC B, V34, P187
[2]   VALUE OF COMPUTED-TOMOGRAPHY AND MEDIASTINOSCOPY IN PREOPERATIVE EVALUATION OF MEDIASTINAL NODES IN NONSMALL CELL LUNG-CANCER - A STUDY OF 569 PATIENTS [J].
DILLEMANS, B ;
DENEFFE, G ;
VERSCHAKELEN, J ;
DECRAMER, M .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1994, 8 (01) :37-42
[3]   Management and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population based study [J].
Gregor, A ;
Thomson, CS ;
Brewster, DH ;
Stroner, PL ;
Davidson, J ;
Fergusson, RJ ;
Milroy, R .
THORAX, 2001, 56 (03) :212-217
[4]   Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging [J].
Gupta, NC ;
Tamim, WJ ;
Graeber, GG ;
Bishop, HA ;
Hobbs, GR .
CHEST, 2001, 120 (02) :521-527
[5]   The current role of mediastinoscopy in the evaluation of thoracic disease [J].
Hammoud, ZT ;
Anderson, RC ;
Meyers, BF ;
Guthrie, TJ ;
Roper, CL ;
Cooper, JD ;
Patterson, GA .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1999, 118 (05) :894-898
[6]  
HUMPHREY EW, 1990, J THORAC CARDIOV SUR, V100, P837
[7]   Divergent changes in survival for histological types of non-small-cell lung cancer in the southeastern area of The Netherlands since 1975 [J].
Janssen-Heijnen, MLG ;
Schipper, RM ;
Klinkhamer, PJJM ;
Crommelin, MA ;
Mooi, WJ ;
Coebergh, JWW .
BRITISH JOURNAL OF CANCER, 1998, 77 (11) :2053-2057
[8]   Prognostic factors in patients with surgically resected stages I and II non-small cell lung cancer [J].
Jazieh, AR ;
Hussain, M ;
Howington, JA ;
Spencer, HJ ;
Husain, M ;
Grismer, JT ;
Read, RC .
ANNALS OF THORACIC SURGERY, 2000, 70 (04) :1168-1171
[9]   Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer [J].
Keller, SM ;
Adak, S ;
Wagner, H ;
Johnson, DH .
ANNALS OF THORACIC SURGERY, 2000, 70 (02) :358-365
[10]  
Manegold C, 2001, LUNG CANCER-J IASLC, V34, pS53